Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Stroke: trial by jury.

Kennedy R Lees1

  • 1University Department of Medicine and Therapeutics, Gardiner Institute, Western Infirmary, Glasgow G11 6NT, Scotland, UK. k.r.lees@clinmed.gla.ac.uk

European Neurology
|February 14, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Impact of central adjudication of the score on the modified Rankin Scale in an international, randomized, acute stroke trial.

European stroke journal·2025
Same author

Cerebral Small Vessel Disease and Infarct Growth in Acute Ischemic Stroke Treated with Intravenous Thrombolysis.

Translational stroke research·2024
Same author

Editorial.

European stroke journal·2023
Same author

Xanthine oxidase inhibition and white matter hyperintensity progression following ischaemic stroke and transient ischaemic attack (XILO-FIST): a multicentre, double-blinded, randomised, placebo-controlled trial.

EClinicalMedicine·2023
Same author

Does My District Need a Mobile Stroke Unit?

The New England journal of medicine·2021
Same author

Safety and Outcomes of Thrombectomy in Ischemic Stroke With vs Without IV Thrombolysis.

Neurology·2021
Same journal

Combined Olfactory Testing and Substantia Nigra Hyperechogenicity for Diagnostic Differentiation of Parkinson's Disease.

European neurology·2026
Same journal

The Role of Stroke Severity in the Association between Hypoperfusion Intensity Ratio and Futile Reperfusion after Endovascular Treatment.

European neurology·2026
Same journal

The Parkinsonism of Salvador Dalí.

European neurology·2026
Same journal

Disorders of Arousal and Sleep-Related Hypermotor Epilepsy in Adults: A Challenging but Necessary and Critical Distinctive Diagnosis.

European neurology·2026
Same journal

Sex-Specific Phenotypic Characteristics in Obstructive Sleep Apnea: A Comprehensive Analysis of Anthropometric, Hematological, and Metabolic Profiles Stratified by Disease Severity.

European neurology·2026
Same journal

Historical and Clinical Analysis of a Case of Progressive Muscular Atrophy (1853-1871).

European neurology·2026
See all related articles

Clinical trials for acute stroke treatments share similarities with legal proceedings. Collaboration between organizations and regulatory bodies is crucial for developing effective stroke therapies and ensuring trial validity.

Area of Science:

  • Neurology
  • Clinical Trial Design
  • Regulatory Science

Background:

  • Pharmacological interventions for acute stroke require rigorous testing.
  • The process of clinical trials involves multiple stakeholders with distinct roles.
  • Ensuring the integrity and efficiency of clinical trials is paramount for advancing stroke care.

Purpose of the Study:

  • To draw parallels between acute stroke clinical trials and legal jury trials.
  • To describe the relationships between sponsoring organizations, regulatory authorities, and other participants.
  • To highlight recent advancements in trial structures and procedures that enhance reliability.

Main Methods:

  • Comparative analysis of clinical trial structures and legal trial frameworks.
  • Descriptive overview of stakeholder roles and inter-organizational relationships.

Related Experiment Videos

  • Review of recent developments in clinical trial methodologies and governance.

    • Main Results:

    • Acute stroke trials and legal trials share common structural and procedural elements.
    • Effective partnerships are essential for achieving the goal of improved stroke treatments.
    • New structures and procedures significantly reduce the risks associated with impractical, invalid, or unreported trials.

    Conclusions:

    • Improved trial structures increase confidence in identifying effective stroke treatments.
    • These advancements help in discounting ineffective or worthless therapeutic approaches.
    • A collaborative approach is key to advancing the field of acute stroke intervention.